Tag: Pfenex
Ligand Pharmaceuticals to acquire protein therapeutics developer Pfenex
US biopharma company Ligand Pharmaceuticals has signed a deal worth up to $516 million to acquire Pfenex, a development and licensing biotechnology company engaged in ... Read More